openPR Logo
Press release

Waldenstrom Macroglobulinemia Market | Key Players - Baxter International Inc., Teva Pharmaceutical Industries Ltd., Bayer AG, Janssen Pharmaceutica NV (Johnson & Johnson), Merck & Co Inc., Hospira (Pfizer Inc.), Takeda Pharmaceutical Company Limited., Am

01-18-2019 08:32 AM CET | Business, Economy, Finances, Banking & Insurance

Press release from: Fact.MR

/ PR Agency: Fact.MR
Waldenstrom Macroglobulinemia Market | Key Players - Baxter

Waldenstrom macroglobulinemia is a rare cancer and is characterized by high level of immunoglobulin M (IgM) in the serum that causes increased serum viscosity and presence of a lymphoplasmacytic infiltrate in the bone marrow. Waldenstrom macroglobulinemia starts in B cells or B lymphocytes and leads to form large amount of IgM. Treatment options for Waldenstrom macroglobulinemia vary according to the symptoms, although standard treatments are available. In the last few years, medical science has made progress and number of new treatments for Waldenstrom macroglobulinemia have been introduced. However, very few studies have been done to compare the best treatment.

Hence, there is no single treatment available that works for all patients of Waldenstrom macroglobulinemia. Symptomatic Waldenstrom macroglobulinemia patients are kept under observation and do not receive any treatment until symptoms show up. Waldenstrom macroglobulinemia patients showing symptoms such as anemia, hyperviscosity, cold-agglutinin disease, amyloidosis, and peripheral neuropathy are considered for the treatment.

Request For Sample @ https://www.factmr.com/connectus/sample?flag=S&rep_id=2415

Patients that show symptomatic hyperviscosity receive plasmapheresis along with rituximab treatment. In most of the cases of Waldenstrom macroglobulinemia, combination therapy with chemo and immunotherapy is recommended. Patients with Waldenstrom macroglobulinemia may require stem cell transplantation in the later stage. Hence, standard chemotherapy agents such as chlorambucil, bendamustine, cladribine, or fludarabine are not prescribed as a first line therapy as they may affect the stem cells. 

Waldenstrom macroglobulinemia Market: Drivers and Restraints

Improving treatment options and diagnosis rate for Waldenstrom macroglobulinemia is the major factor expected to drive the growth of the Waldenstrom macroglobulinemia market over the forecast period. Researchers have found that targeted therapy agents such as Velcade and Kyprolis are showing improved outcomes.

Increased treatment-seeking rate is the other important factor projected to drive the growth of the global Waldenstrom macroglobulinemia market. However, lack of single standard treatment for all patients and disease complexity are the major factors expected to limit the growth of the global Waldenstrom macroglobulinemia market. High cost of therapy and side effects are some of the other factors expected to lower the treatment-seeking rates and in turn affect the growth of the global market.

Request For Brochure @ https://www.factmr.com/connectus/sample?flag=B&rep_id=2415

Waldenstrom macroglobulinemia Market: Overview

The global market for Waldenstrom macroglobulinemia is expected to witness moderate growth over the forecast period. Targeted therapy segment is expected to witness considerable growth during forecast period due to increased adoption rate for Waldenstrom macroglobulinemia targeted therapy drugs. Hospital is the preferred distribution channel for Waldenstrom macroglobulinemia treatment due to requirement of skilled professionals for planning of Waldenstrom macroglobulinemia treatment. Besides, other therapies such as stem cell transplantation requires highly advanced medical infrastructure. Majority of these treatments are covered under medical part B and hence hospital is a preferred distribution channel for Waldenstrom macroglobulinemia treatments. 

Waldenstrom macroglobulinemia Market: Regional Outlook

Geographically, the global Waldenstrom macroglobulinemia market is segmented into North America, Latin America, Europe, Asia-Pacific excluding Japan (APEJ), Japan and the Middle East and Africa (MEA). North America is expected to be the dominant regional market for Waldenstrom macroglobulinemia owing to high prevalence of the disease and better availability of medical resources. The Waldenstrom macroglobulinemia market in Asia Pacific excluding Japan is expected to grow at a slow rate. Europe is expected to hold second large share in the global Waldenstrom macroglobulinemia market throughout the forecast period. 

Waldenstrom macroglobulinemia Market: Key Players

Examples of some of the players identified in the global market for Waldenstrom macroglobulinemia market include Baxter International Inc., Teva Pharmaceutical Industries Ltd., Bayer AG, Janssen Pharmaceutica NV (Johnson & Johnson), Merck & Co Inc., Hospira (Pfizer Inc.), Takeda Pharmaceutical Company Limited., Amgen Inc., Novartis AG, and (Genentech) F. Hoffman-La Roche AG, among others. 

Report Analysis @ https://www.factmr.com/report/2415/waldenstrom-macroglobulinemia-market

The report is a compilation of first-hand information, qualitative and quantitative assessment by industry analysts, inputs from industry experts and industry participants across the value chain. The report provides in-depth analysis of parent market trends, macro-economic indicators and governing factors along with market attractiveness as per segments. The report also maps the qualitative impact of various market factors on market segments and geographies.

About FactMR
FactMR is a fast-growing market research firm that offers the most comprehensive suite of syndicated and customized market research reports. We believe transformative intelligence can educate and inspire businesses to make smarter decisions. We know the limitations of the one-size-fits-all approach; that's why we publish multi-industry global, regional, and country-specific research reports.

Contact Us
FactMR
11140 Rockville Pike
Suite 400
Rockville, MD 20852
United States
Email: sales@factmr.com
Web: www.factmr.com/
Follow Us on Linkedin: www.linkedin.com/company/factmr/

This release was published on openPR.

Permanent link to this press release:

Copy
Please set a link in the press area of your homepage to this press release on openPR. openPR disclaims liability for any content contained in this release.

You can edit or delete your press release Waldenstrom Macroglobulinemia Market | Key Players - Baxter International Inc., Teva Pharmaceutical Industries Ltd., Bayer AG, Janssen Pharmaceutica NV (Johnson & Johnson), Merck & Co Inc., Hospira (Pfizer Inc.), Takeda Pharmaceutical Company Limited., Am here

News-ID: 1511157 • Views: 325

More Releases from Fact.MR

Sichuan Peppercorn Market 2030 Report Enlightening Development Scope and Busines …
The Recent study by Fact.MR– (leading business and competitive intelligence provider) On global Sichuan Peppercorn market Survey study presents an all in all compilation of the historical, current and future outlook of Sichuan Peppercorn market as well as the factors responsible for such a Sichuan Peppercorn Market growth. The report on the market survey of Sichuan Peppercorn gives estimations of the Size of Sichuan Peppercorn Market and the overall share of
The Global Demand of Halal Transportation Logistics Market, Growth Analysis, Lat …
Worldwide, the Muslim population has been growing at nearly 2% each year, nearly double the growth of the overall global population. This has been consequently adding revenues to the products and services designed under the periphery of Islamic laws. According to a State of the Global Economy report, the Muslim population is expected to spend US$ 3 Tn by 2021, up from US$ 1.9 Tn in 2015. In the U.S. alone,
Sales Forecast of Die Cut Handle Bags Market , Analysis, and Forecast Report til …
The global carry bags market is anticipated to reach a valuation of over US$ 30 billion in 2030, with the growth rate pegged at over 4%. The foodservice industry, being the major revenue attributer for carry bags, remained closed during the first two quarters of 2020, due to the widespread of the COVID-19 outbreak. But it is expected that, the global carry bags market will return to its normal growth
The Global Demand Of Salt Spray Chamber Market, Growth Analysis, Latest Trends A …
The Recent study by Fact.MR– (leading business and competitive intelligence provider) On global Salt Spray Chamber market Survey study presents an all in all compilation of the historical, current and future outlook of Salt Spray Chamber market as well as the factors responsible for such a Salt Spray Chamber Market growth. The report on the market survey of Salt Spray Chamber gives estimations of the Size of Salt Spray Chamber Market

All 5 Releases


More Releases for Waldenstrom

Research Offers 08-Year Forecast on Waldenstrom Macroglobulinemia Market(Chemoth …
Waldenstrom macroglobulinemia is a rare cancer and is characterized by high level of immunoglobulin M (IgM) in the serum that causes increased serum viscosity and presence of a lymphoplasmacytic infiltrate in the bone marrow. Waldenstrom macroglobulinemia starts in B cells or B lymphocytes and leads to form large amount of IgM. Treatment options for Waldenstrom macroglobulinemia vary according to the symptoms, although standard treatments are available. In the last few
04-22-2019 | Health & Medicine
Fact.MR
Waldenstrom Macroglobulinemia Market key Insights Based on Product Type, End-use …
Researchers have found that targeted therapy agents such as Velcade and Kyprolis are showing improved outcomes. Increased treatment-seeking rate is the other important factor projected to drive the growth of the global Waldenstrom Macroglobulinemia Market. However, lack of single standard treatment for all patients and disease complexity are the major factors expected to limit the growth of the global Waldenstrom macroglobulinemia market. High cost of therapy and side effects are
NavigaWaldenstrom Macroglobulinemia Market Expected to Deliver Dynamic Progressi …
Waldenstrom macroglobulinemia is a rare cancer and is characterized by high level of immunoglobulin M (IgM) in the serum, which leads to increased serum viscosity, and presence of a lymphoplasmacytic infiltrate in the bone marrow. Waldenstrom macroglobulinemia starts in B cells or B lymphocytes and leads to excess amount of IgM. Treatment options for Waldenstrom macroglobulinemia vary according to symptoms. In the last few years, medical science has made much
Waldenstrom Macroglobulinemia Market Challenges Analysis by 2026
Waldenstrom macroglobulinemia is a rare cancer and is characterized by high level of immunoglobulin M (IgM) in the serum that causes increased serum viscosity and presence of a lymphoplasmacytic infiltrate in the bone marrow. Waldenstrom macroglobulinemia starts in B cells or B lymphocytes and leads to form large amount of IgM. Treatment options for Waldenstrom macroglobulinemia vary according to the symptoms, although standard treatments are available. In the last few
NavigaWaldenstrom Macroglobulinemia Market Projected to Discern Stable Expansion …
Waldenstrom macroglobulinemia is a rare cancer and is characterized by high level of immunoglobulin M (IgM) in the serum, which leads to increased serum viscosity, and presence of a lymphoplasmacytic infiltrate in the bone marrow. Waldenstrom macroglobulinemia starts in B cells or B lymphocytes and leads to excess amount of IgM. Treatment options for Waldenstrom macroglobulinemia vary according to symptoms. In the last few years, medical science has made much
Waldenstrom Macroglobulinemia Market Trends, Regulations And Competitive Landsca …
Waldenstrom macroglobulinemia is a rare cancer and is characterized by high level of immunoglobulin M (IgM) in the serum that causes increased serum viscosity and presence of a lymphoplasmacytic infiltrate in the bone marrow. Waldenstrom macroglobulinemia starts in B cells or B lymphocytes and leads to form large amount of IgM. Treatment options for Waldenstrom macroglobulinemia vary according to the symptoms, although standard treatments are available. In the last few